LNTH
Lantheus Holdings, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -15.3% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 129 | +5 | 56.22M | $5.58B | +13 | −7 |
| Q1 2026 | 126 | +6 | 62.19M | $3.90B | +10 | −5 |
| Q4 2025 | 120 | -2 | 60.97M | $3.47B | +2 | −3 |
| Q3 2025 | 20 | +2 | 33.16M | $1.70B | +2 | −1 |
| Q2 2025 | 16 | -2 | 29.15M | $2.39B | +1 | −3 |
| Q1 2025 | 15 | 0 | 7.80M | $761.04M | — | — |
| Q4 2024 | 15 | 0 | 6.76M | $604.90M | +2 | −2 |
| Q3 2024 | 14 | 0 | 4.84M | $531.32M | +1 | −1 |
| Q2 2024 | 14 | — | 5.72M | $459.02M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 1.68M | +2.0% | $184.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 1.68M | +2.0% | $184.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 1.26M | +1.2% | $137.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.26M | +1.2% | $137.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Norges Bank ✦ (passive) | 503.02K | +5.8% | $55.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Renaissance Technologies ✦ | 362.03K | +68.0% | $39.73M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 7 | Marshall Wace ✦ | 256.98K | +2986.4% | $28.20M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Millennium Management ✦ | 223.88K | -70.0% | $24.57M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Millennium Management ✦ | 223.88K | -70.0% | $24.57M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 163.42K | -58.7% | $17.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 163.42K | -58.7% | $17.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 163.42K | -58.7% | $17.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Fisher Asset Management ✦ | 153.45K | -2.1% | $16.84M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Arrowstreet Capital ✦ | 103.69K | New | $11.38M | 0.0% | New | 1 | SEC ↗ |
| 15 | Bridgewater Associates ✦ | 70.46K | -35.4% | $7.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 33.89K | -0.1% | $3.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Point72 Asset Management ✦ | 17.42K | -94.8% | $1.91M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 12.31K | -18.6% | $1.35M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 2.29K | -92.7% | $251,437 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Arrowstreet Capital | $11.38M | 0.0% |
Exited
| Citadel Advisors | $24.33M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 401 holders, 70.59M shares, $5.23B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.